ALRTF (ALR Technologies SG) Valuation Rank

View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

ALR Technologies SG Valuation Rank Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

ALR Technologies SG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225

Website

https://www.alrt.com

ALR Technologies SG Ltd is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, which derives maximum revenue, Singapore, and Others.

Executives

Sidney Chan	director, officer: CEO	7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng	director	255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford	director	1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith	director, officer: Chief Commercial Officer	46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak	director	521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas	director	2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein	director, officer: President	13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy	officer: Vice-President - Technologies	114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt	director, 10 percent owner, officer: President	114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106